PharmExec Marketing: Having trouble viewing the email? Click Here

In this ISSUE

Content Marketing's Data Fail: Information Without Insight?

Content Marketing: Too Big to Ignore

Are You Winning or Losing in Pharma 2.0?
Strategy
8 Winning Commercial Portfolio Strategies
Biopharma companies are increasingly leveraging product portfolios to own and dominate strategically important therapeutic areas, writes Stan Bernard
... /Read more/
Advertisement
Read this Front & Center article to see how your Hub can be a Secret Weapon to improve Outcomes.
Learn more
Strategy
Loss of Exclusivity: Strategies to Maximize Product Value
Loss of exclusivity doesn't have to be the death knell for branded drug revenue streams. Pharm Exec offers key approaches to preserving meaningful value well into the post-patent-loss future
... /Read more/
Technology
Digital Disruption is Coming: Are You Ready?
Peter Gassner outlines the steps to stay ahead of the looming shakeup in pharma
... /Read more/
Special Feature
Pharm Exec's 2017 Pipeline Report
The industry is readying for a leap into a new age of complex therapies. Elaborate manufacturing and soaring drug costs, however, loom as deep chasms to cross in bridging the potential with reality
... /Read more/
ADVERTISEMENT
Calendar
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
/ February 8–9, 2017: Speaker Programs 2017/
Philadelphia, PA
/ March 14–16, 2017: eyeforpharma Barcelona 2017 /
Barcelona, Spain
/ May 21–24, 2017: 6th Pharmaceutical Sciences World Congress 2017/
Stockholm, Sweden
Industry update
//inVentiv Health (Burlington, MA) appointed Julie Adrian as managing director for its European operations.//IDEXX Laboratories (Westbrook, ME) announced that Pat Venters has joined as Vice President and Chief Marketing Officer.//SCORR Marketing (Kearney, NE) appointed Kelly DeBoer as director of healthcare.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com